The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
US FIRMS are advising on the merger between pharmaceutical giants Pfizer and Warner-Lambert.
Both companies have instructed New York-based lawyers on the £51.2bn merger - one of the five biggest - which will create the world's second largest pharmaceuticals group.
Pfizer has instructed Cadwalader Wickersham & Taft and Kaye Scholer Fierman Hays & Handler. Warner-Lambert is using Skadden Arps Slate Meagher & Flom and Wachtell Lipton Rosen & Katz.
Linklaters corporate finance partner Stephen Boughton, the lead partner for SmithKline Beecham in its £114bn merger with Glaxo Wellcome, says: "The whole deal is a US company bidding for another US company. "
Victoria Kitcatt, senior legal adviser at Pfizer in the UK, says: "It's not a UK issue so nothing's happening over here at the moment.
"There might be some incidental work in the future for London generated by the merger."